Skip to content


Radiation Oncology


Sort by
Previous Page Page 1 of 81 Next Page
  1. Content type: Research

    Clinical pathways outline criteria for dose homogeneity and critical organ dosimetry. Based upon an internal audit showing suboptimal compliance with dosimetric parameters in whole breast irradiation (WBI), we...

    Authors: Katherine S. Chen, Scott M. Glaser, Allison E. Garda, John A. Vargo, M. Saiful Huq, Dwight E. Heron and Sushil Beriwal

    Citation: Radiation Oncology 2018 13:44

    Published on:

  2. Content type: Research

    Cancer patients frequently search the Internet for treatment options, and hospital websites are seen as reliable sources of knowledge. Guidelines support the use of proton radiotherapy in specific disease site...

    Authors: Mark T. Corkum, Wei Liu, David A. Palma, Glenn S. Bauman, Robert E. Dinniwell, Andrew Warner, Mark V. Mishra and Alexander V. Louie

    Citation: Radiation Oncology 2018 13:43

    Published on:

  3. Content type: Research

    Conventional phantom-based planar dosimetry (2D-PBD) quality assurance (QA) using gamma pass rate (GP (%)) is inadequate to reflect clinically relevant dose error in intensity-modulated radiation therapy (IMRT...

    Authors: Wen-zhao Sun, Dan-dan Zhang, Ying-lin Peng, li Chen, De-hua Kang, Bin Wang and Xiao-wu Deng

    Citation: Radiation Oncology 2018 13:42

    Published on:

  4. Content type: Research

    To appraise the dosimetric features and the quality of the treatment plan for radiosurgery of multiple brain metastases optimized with a novel automated engine and to compare with plans optimized for robotic-b...

    Authors: Krzysztof Slosarek, Barbara Bekman, Jacek Wendykier, Aleksandra Grządziel, Antonella Fogliata and Luca Cozzi

    Citation: Radiation Oncology 2018 13:41

    Published on:

  5. Content type: Research

    Esophageal cancer is an aggressive disease with poor survival rates. A more patient-tailored approach based on predictive biomarkers could improve outcome. We aimed to predict radiotherapy (RT) response by ima...

    Authors: Elodie Melsens, Elly De Vlieghere, Benedicte Descamps, Christian Vanhove, Ken Kersemans, Filip De Vos, Ingeborg Goethals, Boudewijn Brans, Olivier De Wever, Wim Ceelen and Piet Pattyn

    Citation: Radiation Oncology 2018 13:39

    Published on:

  6. Content type: Research

    Linac-based stereotactic radiosurgery or fractionated stereotactic radiotherapy (SRS/FSRT) of multiple brain lesions using volumetric modulated arc therapy (VMAT) is typically performed by a multiple-isocenter...

    Authors: Ruggero Ruggieri, Stefania Naccarato, Rosario Mazzola, Francesco Ricchetti, Stefanie Corradini, Alba Fiorentino and Filippo Alongi

    Citation: Radiation Oncology 2018 13:38

    Published on:

  7. Content type: Research

    PSMA PET/CT visualises prostate cancer residual disease or recurrence at lower PSA levels compared to conventional imaging and results in a change of treatment in a remarkable high number of patients. Radiothe...

    Authors: Nina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, Annika Herlemann, Alexander Buchner, Christian Stief, Chukwuka Eze, Paul Rogowski, Minglun Li, Peter Bartenstein, Ute Ganswindt and Claus Belka

    Citation: Radiation Oncology 2018 13:37

    Published on:

  8. Content type: Research

    68Ga-PSMA-PET-imaging has proven to be a highly sensitive and specific diagnostic element for patients with prostate cancer (PC). Does the standard clinical target volume (CTV) cover the majority of 68Ga-PSMA-PET...

    Authors: K. Schiller, M. Devecka, T. Maurer, M. Eiber, J. Gschwend, M. Schwaiger, S. E. Combs and G. Habl

    Citation: Radiation Oncology 2018 13:36

    Published on:

  9. Content type: Study protocol

    Concurrent chemoradiotherapy is a standard modality for locally advanced esophageal squamous cell carcinoma (ESCC) patients. Cisplatin combined with 5-fluorouracil continuous infusion (PF) remains the standard...

    Authors: Yun Chen, Zhengfei Zhu, Weixin Zhao, Ling Li, Jinjun Ye, Chaoyang Wu, Huarong Tang, Qin Lin, Jiancheng Li, Yi Xia, Yunhai Li, Jialiang Zhou and Kuaile Zhao

    Citation: Radiation Oncology 2018 13:33

    Published on:

  10. Content type: Research

    To evaluate spot-scanning proton arc therapy (SPArc) and multi-field robust optimized intensity modulated proton therapy (RO-IMPT) in treating stage III non-small-cell lung cancer (NSCLC) patients.

    Authors: Xiaoqiang Li, Peyman Kabolizadeh, Di Yan, An Qin, Jun Zhou, Ye Hong, Thomas Guerrero, Inga Grills, Craig Stevens and Xuanfeng Ding

    Citation: Radiation Oncology 2018 13:35

    Published on:

  11. Content type: Research

    The purpose of this study was to evaluate the prognostic impact of Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST) and Response Evaluation Criteria in Solid Tumors (RECIST) and of pre-...

    Authors: Cory Pierson, Taras Grinchak, Casey Sokolovic, Brandi Holland, Teresa Parent, Mark Bowling, Hyder Arastu, Paul Walker and Andrew Ju

    Citation: Radiation Oncology 2018 13:34

    Published on:

  12. Content type: Research

    Tumor-Treating Fields (TTFields) are a novel treatment strategy for glioblastoma (GBM) that is approved for the use concomitantly to adjuvant chemotherapy. Preclinical data suggest a synergistic interaction of...

    Authors: Christoph Straube, Markus Oechsner, Severin Kampfer, Sophia Scharl, Friederike Schmidt-Graf, Jan J. Wilkens and Stephanie E. Combs

    Citation: Radiation Oncology 2018 13:31

    Published on:

  13. Content type: Research

    The incomplete repair (IR) model expresses the cell repair effect from radiation-induced damage over time, which is given little consideration in actual treatment planning. By incorporating the IR model into t...

    Authors: Yushi Wakisaka, Masashi Yagi, Iori Sumida, Masaaki Takashina, Kazuhiko Ogawa and Masahiko Koizumi

    Citation: Radiation Oncology 2018 13:30

    Published on:

  14. Content type: Case report

    Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors occurring in various anatomic regions. Although diagnostic criteria and treatment management are not established, current treatment op...

    Authors: Simon Kirste, Gian Kayser, Anne Zipfel, Anca-Ligia Grosu and Thomas Brunner

    Citation: Radiation Oncology 2018 13:28

    Published on:

  15. Content type: Research

    We hypothesized that hippocampal-sparing radiotherapy via volumetric modulated arc therapy (VMAT) could preserve the neurocognitive function (NCF) of patients with primary brain tumors treated with radiotherapy.

    Authors: Kyung Su Kim, Chan Woo Wee, Jin-Yong Seok, Joo Wan Hong, Jin-Beom Chung, Keun-Yong Eom, Jae-Sung Kim, Chae-Yong Kim, Young Ho Park, Yu Jung Kim and In Ah Kim

    Citation: Radiation Oncology 2018 13:29

    Published on:

  16. Content type: Research

    Volumetric-modulated Dynamic WaveArc therapy (VMDWAT) is a non-coplanar continuous volumetric modulated radiation therapy (VMAT) delivery technique. Here, we monitored mechanical errors and their impact on dos...

    Authors: Hideaki Hirashima, Mitsuhiro Nakamura, Yuki Miyabe, Megumi Uto, Kiyonao Nakamura and Takashi Mizowaki

    Citation: Radiation Oncology 2018 13:27

    Published on:

  17. Content type: Research

    Stereotactic body radiotherapy (SBRT) is an emerging treatment option for liver metastases in patients unsuitable for surgery. We investigated factors associated with clinical outcomes for liver metastases tre...

    Authors: Anand Mahadevan, Oliver Blanck, Rachelle Lanciano, Anuj Peddada, Srinath Sundararaman, David D’Ambrosio, Sanjeev Sharma, David Perry, James Kolker and Joanne Davis

    Citation: Radiation Oncology 2018 13:26

    Published on:

  18. Content type: Research

    To derive and exploit the optimal prescription isodose level (PIL) in inverse optimization of volumetric modulated arc radiotherapy (VMAT) as a potential approach to dose de–escalation in stereotactic body rad...

    Authors: Mark Chan, Matthew Wong, Ronnie Leung, Steven Cheung and Oliver Blanck

    Citation: Radiation Oncology 2018 13:24

    Published on:

  19. Content type: Research

    The objective of the present study was to evaluate the effectiveness of postoperative radiotherapy after breast conserving surgery (BCS) in DCIS in a large patient population treated in clinical practice.

    Authors: Stefanie Corradini, Montserrat Pazos, Stephan Schönecker, Daniel Reitz, Maximilian Niyazi, Ute Ganswindt, Simone Schrodi, Michael Braun, Martin Pölcher, Sven Mahner, Nadia Harbeck, Jutta Engel and Claus Belka

    Citation: Radiation Oncology 2018 13:25

    Published on:

  20. Content type: Research

    The purpose of this study was to perform a dosimetric comparison between proton beam therapy (PBT) and photon radiation therapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who w...

    Authors: Yasuhiro Hirano, Masakatsu Onozawa, Hidehiro Hojo, Atsushi Motegi, Sadatomo Zenda, Kenji Hotta, Shunsuke Moriya, Hidenobu Tachibana, Naoki Nakamura, Takashi Kojima and Tetsuo Akimoto

    Citation: Radiation Oncology 2018 13:23

    Published on:

  21. Content type: Research

    Radiation-induced parotid damage is a common complication in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy to head and neck region, which severely reduce the life quality of those pati...

    Authors: Nan Zhou, Chen Chu, Xin Dou, Weibo Chen, Jian He, Jing Yan, Zhengyang Zhou and Xiaofeng Yang

    Citation: Radiation Oncology 2018 13:22

    Published on:

  22. Content type: Research

    This study provides separate comparisons of 1 × 8 Gy to 5 × 4 Gy for metastatic epidural spinal cord compression (MESCC) in patients with poor, intermediate and favorable survival prognoses.

    Authors: Dirk Rades, Antonio J. Conde-Moreno, Jon Cacicedo, Theo Veninga, Barbara Segedin, Karmen Stanic, Volker Rudat and Steven E. Schild

    Citation: Radiation Oncology 2018 13:21

    Published on:

  23. Content type: Research

    To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may ...

    Authors: Ann-Katrin Exeli, Daniel Kellner, Lukas Exeli, Phil Steininger, Frank Wolf, Felix Sedlmayer and Heinz Deutschmann

    Citation: Radiation Oncology 2018 13:20

    Published on:

Previous Page Page 1 of 81 Next Page

2016 Journal Metrics